Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ05
- Pharmacological subgroupJ05A
- Chemical subgroupJ05AGNon-nucleoside reverse transcriptase inh
- Chemical substanceJ05AG06Doravirine
Where it is registered
Each register with its number of medicines and a few of them.
Canada
Health Canada · 3 medicines
United States
FDA · 3 medicines
Spain
AEMPS · 2 medicines



